surfaceenhanc
laser
desorptionion
time
flight
mass
spectrometri
selditofm
power
tool
screen
potenti
biomark
variou
patholog
condit
howev
low
resolut
mass
accuraci
selditofm
remain
major
obstacl
determin
biolog
ident
potenti
protein
biomark
report
refin
workflow
combin
ziptip
desalt
acetonitril
precipit
highperform
liquid
chromatographi
hplc
separ
matrixassist
laser
desorptionion
time
flight
mass
spectrometri
malditofm
analysi
profil
purif
identif
target
serum
protein
found
selditofm
use
workflow
purifi
ten
target
protein
sera
patient
variou
type
advanc
stage
stage
iiiiv
cancer
protein
identifi
isoform
human
serum
amyloid
protein
saa
famili
without
truncat
ntermin
confirm
western
blot
analysi
differ
saa
express
pattern
observ
malditofm
profil
saa
long
report
biomark
variou
cancer
type
lung
cancer
ovarian
cancer
breast
cancer
howev
studi
found
increas
saa
express
sera
advancedstag
cancer
patient
differ
cancer
type
result
suggest
mayb
saa
use
alon
biomark
specif
cancer
type
surfaceenhanc
laser
desorptionion
time
flight
mass
spectrometri
selditofm
play
import
role
area
biomark
discoveri
last
decad
advantag
simpl
oper
highthroughput
capabl
rel
high
sensit
capabl
profil
small
protein
molecular
weight
less
kda
wide
use
screen
tool
clinic
sampl
led
potenti
protein
biomark
discoveri
mani
cancer
type
includ
lung
cer
prostat
cancer
ovarian
cancer
pediatr
acut
lymphoblast
leukemia
howev
inher
low
resolut
mass
accuraci
prevent
selditofm
applic
identif
target
protein
consequ
mani
report
limit
gener
descript
protein
peak
without
elucid
protein
ident
clinic
patholog
valid
therefor
develop
novel
approach
purif
identif
target
protein
remain
major
challeng
selditofmsbas
biomark
discoveri
use
selditofm
research
shanxi
cancer
hospit
found
cluster
highli
express
protein
molecular
weight
mz
sera
patient
advancedstag
cancer
variou
origin
increas
express
lowmolecularweight
protein
shown
associ
diseas
progress
gener
deterior
patient
condit
studi
develop
approach
combin
ziptip
pipett
tip
desalt
acetonitril
acn
precipit
revers
phase
rp
highperform
liquid
chromatographi
hplc
purif
matrixassist
laser
desorptionion
time
flight
mass
spectrometri
malditofm
analysi
appli
profil
purif
identif
report
protein
data
demonstr
lowmolecularweight
protein
member
human
serum
amyloid
protein
saa
famili
without
truncat
ntermin
studi
use
human
tissu
blood
approv
human
research
ethic
committe
shanxi
cancer
hospit
inform
consent
obtain
particip
patient
healthi
donor
serum
sampl
collect
accord
standard
oper
procedur
describ
previous
store
c
use
sampl
analyz
selditofm
use
weak
cation
exchang
wcx
protein
chip
repres
sampl
high
express
level
target
protein
peak
randomli
chosen
purif
identif
target
protein
revers
phase
resin
revers
phase
hplc
column
mm
mm
purchas
great
eurasia
sci
tech
develop
compani
beij
china
monoclon
antibodi
human
saa
secondari
antibodi
coupl
hrp
purchas
abcam
cambridg
usa
prestain
protein
marker
purchas
invitrogen
cadrlsbad
ca
usa
ultrapur
water
obtain
milliq
system
pipett
tip
pvdf
membran
immobilonp
purchas
millipor
bedford
usa
sequenc
grade
modifi
trypsin
product
promega
madison
wi
usa
acn
formic
acid
fa
jt
baker
phillipsburg
nj
usa
super
enhanc
chemiluminesc
detect
reagent
purchas
applygen
technolog
beij
china
chemic
use
experi
includ
acid
chca
sinapin
acid
sa
trifluoroacet
acid
tfa
dithiothreitol
dtt
iodoacetamid
iam
bovin
serum
albumin
bsa
ammonium
bicarbon
nh
hco
purchas
sigma
aldrich
st
loui
mo
usa
chemic
use
ac
hplc
grade
l
serum
sampl
dilut
l
tfa
water
solvent
serum
sampl
solut
desalt
use
ziptip
pipett
tip
follow
standard
protocol
provid
millipor
protein
elut
l
tfa
acn
evapor
l
vacuum
sampl
solut
mix
matrix
mgml
sa
acn
contain
tfa
ratio
left
crystal
maldi
plate
room
temperatur
malditofm
protein
profil
serum
sampl
perform
use
aximacfr
tm
plu
malditof
mass
spectromet
shimadzu
biotech
japan
equip
puls
nitrogen
laser
oper
nm
maldi
mass
spectra
acquir
linear
mode
detect
mass
rang
set
mz
optim
mz
paramet
laser
power
accumul
shot
optim
sampl
get
best
spectra
detect
instrument
calibr
use
appropri
protein
standard
workflow
chart
purif
identif
target
protein
shown
fig
serum
sampl
first
pretreat
acn
precipit
get
rid
abund
protein
reduc
sampl
complex
detail
l
serum
sampl
thaw
c
dilut
l
water
l
acn
ad
sampl
solut
mixtur
incub
c
min
precipit
sampl
solut
centrifug
g
min
c
supernat
collect
evapor
less
l
reconstitut
solvent
tfa
water
desalt
use
homemad
spe
solid
phase
extract
column
briefli
column
equilibr
sampl
bind
use
solvent
supernat
load
onto
column
time
suffici
bind
wash
use
column
volum
solvent
final
protein
elut
use
ml
acn
contain
tfa
elut
solut
evapor
l
vacuum
small
aliquot
l
analyz
malditofm
trace
target
protein
purif
target
protein
perform
hplc
shimadzu
biotech
japan
flow
rate
mlmin
mobil
phase
use
solvent
tfa
water
solvent
b
acn
contain
tfa
sampl
load
follow
gradient
program
use
solvent
min
solvent
min
solvent
b
min
solvent
b
min
solvent
b
min
solvent
b
min
solvent
b
min
detect
wavelength
set
nm
eluat
collect
base
peak
evapor
less
l
small
amount
l
analyz
malditofm
trace
target
protein
measur
molecular
weight
mass
accuraci
obtain
extern
calibr
linear
mode
protein
within
purifi
target
protein
sampl
alkal
ph
use
mm
nh
nco
reduc
mm
dtt
c
h
treat
iam
concentr
mm
dark
min
g
trypsin
ad
sampl
solut
incub
c
overnight
digest
end
ad
tfa
final
concentr
next
morn
digest
sampl
analyz
use
malditof
mass
spectromet
reflect
mode
chca
mgml
acn
contain
tfa
matrix
obtain
peptid
mass
fingerprint
pmf
spectra
detect
mass
rang
set
mz
optim
mz
detect
instrument
calibr
use
appropri
peptid
standard
pmf
spectra
process
use
launchpad
softwar
shimadzu
biotech
japan
search
onlin
use
mascot
algorithm
ncbinr
human
databas
mass
toler
set
da
calcul
use
mono
isotop
mass
enzym
cleavag
specif
set
trypsin
one
miss
cleavag
allow
fix
modif
set
cystein
carbamidomethyl
addit
da
variabl
modif
set
methionin
oxid
addit
da
result
filter
use
default
paramet
p
western
blot
experi
perform
valid
identif
result
sampl
l
serum
dilut
l
water
fulli
mix
l
electrophoresi
load
buffer
vortex
shake
heat
c
min
centrifug
g
min
cool
room
temperatur
equal
amount
l
equival
l
origin
serum
supernat
sampl
load
sdspage
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
separ
protein
band
transfer
pvdf
membran
mm
tri
mm
glycin
methanol
block
bsa
tbst
trisbuff
salin
mm
trishcl
mm
nacl
ph
c
overnight
protein
probe
mous
antihuman
saa
antibodi
gml
c
h
wash
three
time
tbst
incub
goat
antimous
igg
h
l
hrp
horseradish
peroxidas
secondari
antibodi
gml
room
temperatur
h
wash
tbst
three
time
protein
detect
enhanc
chemiluminesc
malditofm
success
use
obtain
lowmolecularweight
protein
profil
human
serum
fig
fig
show
malditofm
spectra
right
much
higher
resolut
mass
accuraci
selditofm
spectra
left
target
mass
rang
mz
therefor
target
protein
could
trace
use
malditofm
purif
malditofm
provid
reliabl
profil
method
high
reproduc
shown
fig
target
protein
present
spectra
advancedstag
cancer
patient
sera
protein
repeatedli
observ
spectra
acn
precipit
perform
first
get
rid
larg
highabund
protein
serum
supplementari
fig
precipit
ms
analysi
serum
lowmolecularweight
protein
greatli
improv
enhanc
signal
intens
higher
resolut
supplementari
fig
facilit
trace
target
protein
rp
hplc
separ
carri
next
target
protein
found
elut
use
solvent
b
supplementari
fig
use
workflow
ten
target
protein
purifi
human
serum
sampl
advancedstag
cancer
patient
fig
observ
mz
valu
purifi
protein
digest
trypsin
analyz
malditofm
confid
identifi
seri
isoform
human
serum
amyloid
saa
truncat
saa
onlin
mascot
search
engin
combin
accur
molecular
weight
inform
pmf
result
whole
amino
acid
sequenc
purifi
protein
assign
tabl
tabl
indic
identifi
target
protein
includ
three
form
one
one
three
two
respect
pmf
spectra
databas
search
result
shown
supplementari
fig
heterogen
human
saa
report
earlier
base
identif
result
examin
protein
peak
purifi
also
target
mass
rang
protein
peak
found
similar
perform
identifi
saa
protein
observ
molecular
mass
good
accord
report
saa
isoform
without
ntermin
truncat
therefor
conceiv
protein
similarli
belong
saa
famili
identifi
specul
saa
isoform
clarifi
saa
express
pattern
sera
patient
differ
type
advancedstag
cancer
profil
serum
sampl
data
shown
use
method
describ
section
divers
saa
express
pattern
discov
differ
peak
number
variou
peak
combin
distinct
signal
intens
fig
made
effort
find
correl
differ
pattern
cancer
type
tumor
site
could
draw
statist
signific
conclus
far
mayb
amount
sampl
small
studi
multipl
cancer
type
mayb
saa
expression
differ
simpli
due
molecular
heterogen
person
person
show
nedelkov
et
al
investig
divers
human
protein
western
blot
experi
perform
result
valid
result
indic
sera
termin
cancer
patient
show
obviou
chemiluminesc
lane
saa
saa
could
detect
sera
healthi
control
use
volum
serum
furthermor
saa
protein
abund
reveal
western
blot
consist
malditofm
profil
correspond
sampl
fig
studi
establish
effici
workflow
profil
purif
identif
lowabund
lowmolecularweight
target
protein
human
serum
simpl
fast
robust
method
readili
adopt
similar
studi
use
workflow
purifi
identifi
ten
saa
isoform
without
truncat
sera
advancedstag
cancer
patient
purifi
first
time
although
detect
human
saa
protein
use
malditofm
previous
report
studi
appear
first
detect
larg
number
saa
isoform
high
mass
accuraci
resolut
protein
identifi
studi
belong
acut
phase
saa
famili
major
acutephas
reactant
suggest
immunerel
function
secret
acut
phase
inflamm
take
part
process
includ
transport
cholesterol
recruit
immun
cell
induct
enzym
saa
long
hotspot
field
biomark
research
elev
express
level
saa
report
mani
type
cancer
includ
nasopharyng
cancer
ovarian
cancer
lung
cancer
pancreat
cancer
prostat
cancer
colorect
cancer
breast
cancer
gastric
cancer
pediatr
osteosarcoma
neuroblastoma
renal
cell
carcinoma
diseas
amyloidosi
coronari
arteri
diseas
rheumatoid
arthriti
sever
acut
respiratori
syndrom
studi
detect
saa
sera
multipl
cancer
type
first
time
found
high
express
level
saa
sera
almost
advancedstag
cancer
patient
base
previou
studi
seem
saa
may
biomark
indic
deterior
physic
condit
found
advancedstag
cancer
use
alon
biomark
specif
cancer
type
author
declar
conflict
interest
